Fig. 1 · Structure
Documents & Downloads
β-D-Galactose pentaacetate
Insulin Antagonist
β-D-Galactose pentaacetate functions as an insulin antagonist, exhibiting the ability to penetrate cell membranes and be hydrolyzed by intracellular esterases. This compound effectively inhibits Leucine-induced insulin release in Wistar rat islets, suggesting its potential in mitigating excessive insulin secretion in pathological conditions. Its regulatory role in insulin signaling makes it a valuable tool for research in metabolic disorders and diabetes.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 4163-60-4 |
| Applications | Insulin Antagonist |
| Formula | C16H22O11 |
| Molecular Weight | 390.34 |
| SMILES | CC(O[C@H]1[C@H]([C@H](O[C@H]([C@@H]1OC(C)=O)OC(C)=O)COC(C)=O)OC(C)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.